A, Tripathi, and Bankaitis VA. 2018. “Molecular Docking: From Lock and Key to Combination Lock.” Journal of Molecular Medicine and Clinical Applications 2(1).

Åberg, Veronica et al. 2008. “Carboxylic Acid Isosteres Improve the Activity of Ring-Fused 2-Pyridones That Inhibit Pilus Biogenesis in E. Coli.” Bioorganic and Medicinal Chemistry Letters 18(12): 3536–40.

Aguilar, Angelo et al. 2017. “Discovery of 4-((3′R,4′S,5′R)-6-Chloro-4′-(3-Chloro-2-Fluorophenyl)-1′-Ethyl-2-Oxodispiro[cyclohexane-1,2′-Pyrrolidine-3′,3-Indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-Carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development.” Journal of Medicinal Chemistry 60(7): 2819–39.

Alberts, David S. et al. 1996. “Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer.” New England Journal of Medicine 335(26): 1950–55.

Amano, Yasushi, Tomohiko Yamaguchi, and Eiki Tanabe. 2014. “Structural Insights into Binding of Inhibitors to Soluble Epoxide Hydrolase Gained by Fragment Screening and X-Ray Crystallography.” Bioorganic and Medicinal Chemistry 22(8): 2427–34.

de Araujo, Elvin D. et al. 2019. “Structural and Functional Consequences of the STAT5BN642H Driver Mutation.” Nature Communications 10(1).

de Araujo, Elvin D., György M. Keserű, Patrick T. Gunning, and Richard Moriggl. 2020. “Targeting STAT3 and STAT5 in Cancer.” Cancers 12(8): 1–8.

Attwood, Misty M. et al. 2021. “Trends in Kinase Drug Discovery: Targets, Indications and Inhibitor Design.” Nature Reviews Drug Discovery 20(11): 839–61.

Ballatore, Carlo, Donna M. Huryn, and Amos B. Smith. 2013. “Carboxylic Acid (Bio)Isosteres in Drug Design.” ChemMedChem 8(3): 385–95.

Bennett, Joan W., and King Thom Chung. 2001. “Alexander Fleming and the Discovery of Penicillin.” Advances in Applied Microbiology 49: 163–84.

Bordon, Yvonne. 2016. “The Many Sides of Paul Ehrlich.” Nature Immunology 17(S1): S6–S6.

Bosch, Fèlix, and Laia Rosich. 2008. “The Contributions of Paul Ehrlich to Pharmacology: A Tribute on the Occasion of the Centenary of His Nobel Prize.” Pharmacology 82(3): 171–79.

Bregante, Javier et al. 2021. “Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia.” Cancers 13(24).

Brook, Karolina, Jessica Bennett, and Sukumar P. Desai. 2017. “The Chemical History of Morphine: An 8000-Year Journey, from Resin to de-Novo Synthesis.” Journal of Anesthesia History 3(2): 50–55.

Carr, Robin A.E., Miles Congreve, Christopher W. Murray, and David C. Rees. 2005. “Fragment-Based Lead Discovery: Leads by Design.” Drug Discovery Today 10(14): 987–92.

Chalmers, Benjamin A. et al. 2016. “Validating Eaton’s Hypothesis: Cubane as a Benzene Bioisostere.” Angewandte Chemie – International Edition 55(11): 3580–85.

Cho, Naoki et al. 2017. “Identification of Novel Glutathione Adducts of Benzbromarone in Human Liver Microsomes.” Drug Metabolism and Pharmacokinetics 32(1): 46–52.

Clader, John W. 2004. “The Discovery of Ezetimibe: A View from Outside the Receptor.” Journal of Medicinal Chemistry 47(1): 1–9.

Cohen, Philip, Darren Cross, and Pasi A. Jänne. 2021. “Kinase Drug Discovery 20 Years after Imatinib: Progress and Future Directions.” Nature Reviews Drug Discovery 20(7): 551–69.

Conner, Kip P., Caleb M. Woods, and William M. Atkins. 2011. “Interactions of Cytochrome P450s with Their Ligands.” Archives of Biochemistry and Biophysics 507(1): 56–65.

Crawford, James J. et al. 2012. “Pharmacokinetic Benefits of 3,4-Dimethoxy Substitution of a Phenyl Ring and Design of Isosteres Yielding Orally Available Cathepsin K Inhibitors.” Journal of Medicinal Chemistry 55(20): 8827–37.

Currie, Geoffrey M. 2018. “Pharmacology, Part 2: Introduction to Pharmacokinetics.” Journal of Nuclear Medicine Technology 46(3): 221–30.

Dalvie, Deepak K. et al. 2002. “Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings.” Chemical Research in Toxicology 15(3): 269–99.

Dalvie, Deepak K., and Bernard Testa. 2021. “Principles of Drug Metabolism.” In Burger’s Medicinal Chemistry and Drug Discovery, , 1–139.

Dang, Na Le, Tyler B. Hughes, Grover P. Miller, and S. Joshua Swamidass. 2017. “Computational Approach to Structural Alerts: Furans, Phenols, Nitroaromatics, and Thiophenes.” Chemical Research in Toxicology 30(4): 1046–59.

Desborough, Michael J.R., and David M. Keeling. 2017. “The Aspirin Story – from Willow to Wonder Drug.” British Journal of Haematology 177(5): 674–83.

Dzobo, Kevin. 2022. “The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery.” In Comprehensive Pharmacology, , 408–22.

Eh-Haj, Babiker M. 2021. “Metabolic N-Dealkylation and N-Oxidation as Elucidators of the Role of Alkylamino Moieties in Drugs Acting at Various Receptors.” Molecules 26(7).

Elumalai, Nagarajan et al. 2015. “Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a.” Angewandte Chemie – International Edition 54(16): 4758–63.

Elumalai, Nagarajan et al. 2017. “Rational Development of Stafib-2: A Selective, Nanomolar Inhibitor of the Transcription Factor STAT5b.” Scientific Reports 7(1).

Feng, Minghao, Bingqing Tang, Steven H. Liang, and Xuefeng Jiang. 2016. “Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry.” Current Topics in Medicinal Chemistry 16(11): 1200–1216.

Ferreira, Leonardo G., and Adriano D. Andricopulo. 2017. “From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.” Current Topics in Medicinal Chemistry 17(20).

Gadducci, Angiolo et al. 2000. “Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest.” Gynecologic Oncology 76(2): 157–62.

Gauthier, Jacques Yves et al. 2008. “The Discovery of Odanacatib (MK-0822), a Selective Inhibitor of Cathepsin K.” Bioorganic and Medicinal Chemistry Letters 18(3): 923–28.

Gourley, Charlie, Joan L. Walker, and Helen J. Mackay. 2016. “Update on Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer.” American Society of Clinical Oncology Educational Book (36): 143–51.

Hauser, Alexander S. et al. 2017. “Trends in GPCR Drug Discovery: New Agents, Targets and Indications.” Nature Reviews Drug Discovery 16(12): 829–42.

Hitchcock, Stephen A. 2012. “Structural Modifications That Alter the P-Glycoprotein Efflux Properties of Compounds.” Journal of Medicinal Chemistry 55(11): 4877–95.

Ho, Teresa T. et al. 2023. “Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome.” Journal of Personalized Medicine 13(2).

Huang, Guang, Devon Hucek, Tomasz Cierpicki, and Jolanta Grembecka. 2023. “Applications of Oxetanes in Drug Discovery and Medicinal Chemistry.” European Journal of Medicinal Chemistry 261.

Hughes, J. P., S. S. Rees, S. B. Kalindjian, and K. L. Philpott. 2011. “Principles of Early Drug Discovery.” British Journal of Pharmacology 162(6): 1239–49.

Hukkanen, Janne, Peyton Jacob, and Neal L. Benowitz. 2005. “Metabolism and Disposition Kinetics of Nicotine.” Pharmacological Reviews 57(1): 79–115.

Richardson, Samantha, April Bai, Ashutosh A. Kulkarni, and Mehran F. Moghaddam. 2016. “Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability.” Drug Metabolism Letters 10(2): 83–90.

Janov, Petra, and Michal iller. 2012. “Phase II Drug Metabolism.” In Topics on Drug Metabolism,.

Jedwabny, Wiktoria, and Edyta Dyguda-Kazimierowicz. 2019. “Revisiting the Halogen Bonding between Phosphodiesterase Type 5 and Its Inhibitors.” Journal of Molecular Modeling 25(2).

Jeffrey, P. 2004. “The Practice of Medicinal Chemistry.” British Journal of Clinical Pharmacology 57(5): 662–662.

Junod, Suzanne. 2008. “FDA and Clinical Drug Trials: A Short History.” Quick Guide to Clinical Trials: 25–55. www.fda.gov.

Kalgutkar, Amit S. 2020. “Designing around Structural Alerts in Drug Discovery.” Journal of Medicinal Chemistry 63(12): 6276–6302.

Kalra, Arjun, and Faiz Tuma. 2018. StatPearls Physiology, Liver. http://www.ncbi.nlm.nih.gov/pubmed/30571059.

Kenny, Peter W. 2019. “The Nature of Ligand Efficiency.” Journal of Cheminformatics 11(1).

Kikuchi, Satoshi et al. 2016. “Prolonged Hypotension Induced by Ingesting a Topical Minoxidil Solution: Analysis of Minoxidil and Its Metabolites.” Acute Medicine & Surgery 3(4): 384–87.

Kim, Jonathan, Rosemary J. Cater, Brendon C. Choy, and Filippo Mancia. 2021. “Structural Insights into Transporter-Mediated Drug Resistance in Infectious Diseases.” Journal of Molecular Biology 433(16).

Kirk, Kenneth. 2006. “Selective Fluorination in Drug Design and Development: An Overview of Biochemical Rationales.” Current Topics in Medicinal Chemistry 6(14): 1447–56.

Kirsch, Philine, Alwin M. Hartman, Anna K.H. Hirsch, and Martin Empting. 2019. “Concepts and Core Principles of Fragment-Based Drug Design.” Molecules 24(23).

Kumari, Shikha, Angelica V. Carmona, Amit K. Tiwari, and Paul C. Trippier. 2020. “Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.” Journal of Medicinal Chemistry 63(21): 12290–358.

Liang, Jun et al. 2016. “Lead Optimization of a pyrazolo[1,5-A]pyrimidin-7(4H)-One Scaffold to Identify Potent, Selective and Orally Bioavailable KDM5 Inhibitors Suitable for in Vivo Biological Studies.” Bioorganic and Medicinal Chemistry Letters 26(16): 4036–41.

Limban, Carmen et al. 2018. “The Use of Structural Alerts to Avoid the Toxicity of Pharmaceuticals.” Toxicology Reports 5: 943–53.

Lipinski, Christopher A. 2004. “Lead- and Drug-like Compounds: The Rule-of-Five Revolution.” Drug Discovery Today: Technologies 1(4): 337–41.

Madden, Judith C., Steven J. Enoch, Alicia Paini, and Mark T.D. Cronin. 2020. “A Review of In Silico Tools as Alternatives to Animal Testing: Principles, Resources and Applications.” ATLA Alternatives to Laboratory Animals 48(4): 146–72.

Magalhães, Pedro R. et al. 2021. “Identification of Pan-Assay INterference compoundS (PAINS) Using an MD-Based Protocol.” In Methods in Molecular Biology, , 263–71.

Mahanta, Nilkamal, D. Miklos Szantai-Kis, E. James Petersson, and Douglas A. Mitchell. 2019. “Biosynthesis and Chemical Applications of Thioamides.” ACS Chemical Biology.

Di Martino, Rita Maria Concetta, Brad D. Maxwell, and Tracey Pirali. 2023. “Deuterium in Drug Discovery: Progress, Opportunities and Challenges.” Nature Reviews Drug Discovery 22(7): 562–84.

Matthews, Holly, James Hanison, and Niroshini Nirmalan. 2016. “‘Omics’-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives.” Proteomes 4(3).

McEneny-King, Alanna, Andrea N. Edginton, and Praveen P.N. Rao. 2015. “Investigating the Binding Interactions of the Anti-Alzheimer’s Drug Donepezil with CYP3A4 and P-Glycoprotein.” Bioorganic and Medicinal Chemistry Letters 25(2): 297–301.

Meanwell, Nicholas A. 2011. “Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design.” Journal of Medicinal Chemistry 54(8): 2529–91.

Meanwell, Nicholas A.. 2014. “The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems.” Topics in Medicinal Chemistry 9: 283–382.

Meunier, Bernard, Samuël P. de Visser, and Sason Shaik. 2004. “Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes.” Chemical Reviews 104(9): 3947–80.

Mykhailiuk, Pavel K. 2019. “Saturated Bioisosteres of Benzene: Where to Go Next?” Organic and Biomolecular Chemistry 17(11): 2839–49.

Nikaido, Hiroshi. 2018. “RND Transporters in the Living World.” Research in Microbiology 169(7–8): 363–71.

Oprea, Tudor I., Andrew M. Davis, Simon J. Teague, and Paul D. Leeson. 2001. “Is There a Difference between Leads and Drugs? A Historical Perspective.” Journal of Chemical Information and Computer Sciences 41(3–6): 1308–15.

Orlova, Anna et al. 2019. “Direct Targeting Options for STAT3 and STAT5 in Cancer.” Cancers 11(12): 1930.

Ortwine, Daniel F., and Ignacio Aliagas. 2013. “Physicochemical and DMPK in Silico Models: Facilitating Their Use by Medicinal Chemists.” Molecular Pharmaceutics 10(4): 1153–61.

Pfaff, Annalise R., Justin Beltz, Emily King, and Nuran Ercal. 2019. “Medicinal Thiols: Current Status and New Perspectives.” Mini-Reviews in Medicinal Chemistry 20(6): 513–29.

Pinheiro, Pedro de Sena Murteira, Lucas Silva Franco, and Carlos Alberto Manssour Fraga. 2023. “The Magic Methyl and Its Tricks in Drug Discovery and Development.” Pharmaceuticals 16(8).

Pirali, Tracey, Marta Serafini, Sarah Cargnin, and Armando A. Genazzani. 2019. “Applications of Deuterium in Medicinal Chemistry.” Journal of Medicinal Chemistry 62(11): 5276–97.

Polanski, Jaroslaw, Aleksandra Tkocz, and Urszula Kucia. 2017. “Beware of Ligand Efficiency (LE): Understanding LE Data in Modeling Structure-Activity and Structure-Economy Relationships.” Journal of Cheminformatics 9(1).

Prachayasittikul, Veda, and Virapong Prachayasittikul. 2016. “P-Glycoprotein Transporter in Drug Development.” EXCLI Journal 15: 113–18.

Qiao, Jennifer X. et al. 2008. “Achieving Structural Diversity Using the Perpendicular Conformation of Alpha-Substituted Phenylcyclopropanes to Mimic the Bioactive Conformation of Ortho-Substituted Biphenyl P4 Moieties: Discovery of Novel, Highly Potent Inhibitors of Factor Xa.” Bioorganic and Medicinal Chemistry Letters 18(14): 4118–23.

Ress, David C., Miles Congreve, Christopher W. Murray, and Robin Carr. 2004. “Fragment-Based Lead Discovery.” Nature Reviews Drug Discovery 3(8): 660–72.

Roskoski, Robert. 2016. “Classification of Small Molecule Protein Kinase Inhibitors Based upon the Structures of Their Drug-Enzyme Complexes.” Pharmacological Research 103: 26–48.

Sneader, W. 2000. “The Discovery of Aspirin: A Reappraisal.” British Medical Journal 321(7276): 1591–94.

Sohlenius-Sternbeck, Anna-Karin et al. 2016. “Optimizing DMPK Properties: Experiences from a Big Pharma DMPK Department.” Current Drug Metabolism 17(3): 253–70.

Subbaiah, Murugaiah A.M., and Nicholas A. Meanwell. 2021. “Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design.” Journal of Medicinal Chemistry 64(19): 14046–128.

Topiol, Sid. 2018. “Current and Future Challenges in GPCR Drug Discovery.” In Methods in Molecular Biology, , 1–21.

Tortora, Gerard J, and Bryan Derrickson. 2014. “Tortora Principles of Anatomy and Physiology 14th Edition.” Physiology 86(10): 555.

Umezawa, Koji, and Isao Kii. 2021. “Druggable Transient Pockets in Protein Kinases.” Molecules 26(3).

Vaz, Alfin. 2005. “Multiple Oxidants in Cytochrome P450 Catalyzed Reactions Implications for Drug Metabolism.” Current Drug Metabolism 2(1): 1–16.

Walsh, C. T. et al. 1996. “Bacterial Resistance to Vancomycin: Five Genes and One Missing Hydrogen Bond Tell the Story.” Chemistry and Biology 3(1): 21–28.

Wang, Hui et al. 2019. “Glutathione Conjugation and Protein Adduction Derived from Oxidative Debromination of Benzbromarone in Mice.” Drug Metabolism and Disposition 47(11): 1281–90.

Wermuth, Camille Georges, David Aldous, Pierre Raboisson, and Didier Rognan. 2015. The Practice of Medicinal Chemistry: Fourth Edition The Practice of Medicinal Chemistry: Fourth Edition.

Wiesenfeldt, Mario P. et al. 2023. “General Access to Cubanes as Benzene Bioisosteres.” Nature 618(7965): 513–18.

Wilhelm, Scott et al. 2007. “Erratum: Discovery and Development of Sorafenib: A Multikinase Inhibitor for Treating Cancer.” Nature Reviews Drug Discovery 6(2): 168–168.

Wójcikowski, Jacek, Patrick Maurel, and Władysława A. Daniel. 2006. “Characterization of Human Cytochrome P450 Enzymes Involved in the Metabolism of the Piperidine-Type Phenothiazine Neuroleptic Thioridazine.” Drug Metabolism and Disposition 34(3): 471–76.

Wrobleski, Stephen T. et al. 2019. “Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165.” Journal of Medicinal Chemistry 62(20): 8973–95.

Yue, Qin et al. 2013. “Evaluation of Metabolism and Disposition of GDC-0152 in Rats Using 14C Labeling Strategy at Two Different Positions: A Novel Formation of Hippuric Acid from 4-Phenyl-5-Amino-1,2,3-Thiadiazoles.” Drug Metabolism and Disposition 41(2): 508–17.

Zhang, Ming Qiang, and Barrie Wilkinson. 2007. “Drug Discovery beyond the ‘Rule-of-Five.’” Current Opinion in Biotechnology 18(6): 478–88.

Cover Image

The image used on the cover of “Test tubes for column chromatography” by Bilal Saqib (CC BY-NC-SA)